Incretin-Based Multi-Agonist Peptides Are Neuroprotective and Anti-Inflammatory in Cellular Models of Neurodegeneration.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Incretin-Based Multi-Agonist Peptides Are Neuroprotective and Anti-Inflammatory in Cellular Models of Neurodegeneration.
- Published In:
- Biomolecules, 14(7) (2024)
- Authors:
- Kopp, Katherine O, Li, Yazhou(4), Glotfelty, Elliot J, Tweedie, David, Greig, Nigel H
- Database ID:
- RPEP-08581
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-08581APA
Kopp, Katherine O; Li, Yazhou; Glotfelty, Elliot J; Tweedie, David; Greig, Nigel H. (2024). Incretin-Based Multi-Agonist Peptides Are Neuroprotective and Anti-Inflammatory in Cellular Models of Neurodegeneration.. Biomolecules, 14(7). https://doi.org/10.3390/biom14070872
MLA
Kopp, Katherine O, et al. "Incretin-Based Multi-Agonist Peptides Are Neuroprotective and Anti-Inflammatory in Cellular Models of Neurodegeneration.." Biomolecules, 2024. https://doi.org/10.3390/biom14070872
RethinkPeptides
RethinkPeptides Research Database. "Incretin-Based Multi-Agonist Peptides Are Neuroprotective an..." RPEP-08581. Retrieved from https://rethinkpeptides.com/research/kopp-2024-incretinbased-multiagonist-peptides-are
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.